Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arcadia Biosciences (RKDA) has provided an announcement.
Arcadia Biosciences announced key executive changes, with Stanley Jacot resigning as president, CEO, and director, and the company agreeing to a hefty severance package including cash, stock option vesting, and health insurance coverage. Thomas J. Schaefer steps up as the new CEO, bringing a wealth of finance experience and a solid educational background. Mark Kawakami fills Schaefer’s former CFO role, equipped with a strong analytical background and diverse financial expertise.
Find detailed analytics on RKDA stock on TipRanks’ Stock Analysis page.